FRTXFresh Tracks Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsNov 13
Mkt Cap$5.59M
Vol2,912.00

About

Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in September 2009 and is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Fresh Tracks Therapeutics Inc?
What is the 52-week high for Fresh Tracks Therapeutics Inc?
What is the 52-week low for Fresh Tracks Therapeutics Inc?
What is Fresh Tracks Therapeutics Inc stock price today?
What was Fresh Tracks Therapeutics Inc stock price yesterday?
What is the PE ratio of Fresh Tracks Therapeutics Inc?
What is the Price-to-Book ratio of Fresh Tracks Therapeutics Inc?
What is the 50-day moving average of Fresh Tracks Therapeutics Inc?

Latest FRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.